ATXN3 and breast carcinoma: To determine the clinical relevance of TSPAN8- and ATXN3-regulated PTCH1/SHH stability, we performed IHC staining of 90 breast cancer specimens and found that the expression of TSPAN8 in the tumor tissue was higher than that in the adjacent non-tumor tissue (Fig. 7a).